» Authors » Keonte J Graves

Keonte J Graves

Explore the profile of Keonte J Graves including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 52
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Gerwen O, Aaron K, Kay E, Siwakoti K, Pontius A, Richter S, et al.
J Infect Dis . 2025 Mar; PMID: 40037329
Background: Understanding the impact of testosterone on the vaginal microbiota of transgender men (TGM) and non-binary people assigned female sex at birth over time is imperative as vaginal dysbiosis and...
2.
Giacani L, Bradshaw C, Muzny C, Graves K, Pasricha S, Jordan S, et al.
Curr HIV/AIDS Rep . 2025 Jan; 22(1):14. PMID: 39856345
Purpose Of Review: Antimicrobial resistance in sexually transmitted infections (STIs) has become an urgent global public health threat, raising the specter of untreatable infections. This review summarizes the determinants of...
3.
Van Gerwen O, Sherman Z, Kay E, Wall J, Lewis J, Eastlund I, et al.
PLoS One . 2024 Aug; 19(8):e0308603. PMID: 39133717
Background: Transgender men (TGM) are underrepresented in genital microbiome research. Our prospective study in Birmingham, AL investigated genital microbiota changes over time in TGM initiating testosterone, including the development of...
4.
Graves K, Novak J, Tiwari H, Evan Secor W, Augostini P, Muzny C
Sex Transm Dis . 2024 Apr; 51(11):e43-e45. PMID: 38687328
We determined the in vitro minimum lethal concentration of secnidazole and assessed the correlation with clinical susceptibility among Trichomonas vaginalis isolates obtained from 71 women, of whom 66 were successfully...
5.
Muzny C, Elnaggar J, Sousa L, Lima A, Aaron K, Eastlund I, et al.
BMJ Open . 2024 Feb; 14(2):e083516. PMID: 38316599
Introduction: The aetiology of bacterial vaginosis (BV), a biofilm-associated vaginal infection, remains unknown. Epidemiologic data suggest that it is sexually transmitted. BV is characterised by loss of lactic acid-producing lactobacilli...
6.
Graves K, Reily C, Tiwari H, Srinivasasainagendra V, Secor W, Novak J, et al.
Pathogens . 2023 May; 12(5). PMID: 37242362
is the most common non-viral sexually transmitted infection. 5-nitroimidazoles are the only FDA-approved medications for treatment. However, 5-nitroimidazole resistance has been increasingly recognized and may occur in up to 10%...
7.
Van Gerwen O, Opsteen S, Graves K, Muzny C
Infect Dis Clin North Am . 2023 Apr; 37(2):245-265. PMID: 37005163
Trichomoniasis is the most common nonviral sexually transmitted infection worldwide. It has been associated with a variety of adverse sexual and reproductive health outcomes for both men and women. In...
8.
Muzny C, Van Gerwen O, Schroeder J, Kay-Duncan E, Siwakoti K, Aaron K, et al.
BMJ Open . 2023 Mar; 13(3):e073068. PMID: 36972958
Introduction: The effect of testosterone (T) therapy on the vaginal microbiota of transgender men (TGM) is not well characterised, although one cross-sectional study comparing the vaginal microbiota of cisgender women...
9.
Muzny C, Schwebke J, Nyirjesy P, Kaufman G, Mena L, Lazenby G, et al.
Clin Infect Dis . 2021 Mar; 73(6):e1282-e1289. PMID: 33768237
Background: Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection. We evaluated the efficacy and safety of secnidazole vs placebo in women with trichomoniasis. Methods: Women with trichomoniasis, confirmed...
10.
Graves K, Novak J, Evan Secor W, Kissinger P, Schwebke J, Muzny C
Parasitology . 2020 Jul; 147(13):1383-1391. PMID: 32729451
Background: Trichomonas vaginalis is the most common non-viral sexually transmitted infection. 5-Nitroimidazoles [metronidazole (MTZ) and tinidazole (TDZ)] are FDA-approved treatments. To better understand treatment failure, we conducted a systematic review...